These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 445610

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Uterine hemorrhage during intrauterine contraception. Pathophysiology and therapy].
    Tauber PF.
    Med Welt; 1979 Oct 19; 30(42):1547-53. PubMed ID: 93677
    [No Abstract] [Full Text] [Related]

  • 3. [Complications of contraception with intra-uterine devices].
    Gelpke W.
    Geburtshilfe Frauenheilkd; 1972 Oct 19; 32(10):908-9. PubMed ID: 4652288
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Management of uterine bleeding by PGs or their synthesis inhibitors.
    Toppozada M, El-Attar A, El-Ayyat MA, Khamis Y.
    Adv Prostaglandin Thromboxane Res; 1980 Oct 19; 8():1459-63. PubMed ID: 6769315
    [Abstract] [Full Text] [Related]

  • 8. [Risks of contraception using intrauterine devices].
    Welti H.
    Ther Umsch; 1986 May 19; 43(5):400-3. PubMed ID: 3726776
    [No Abstract] [Full Text] [Related]

  • 9. [Results of bleeding prevention with fibrinolysis inhibitors in intrauterine contraception].
    Tauber PF, Werling E, Klöppel A, Ludwig H.
    Arch Gynecol; 1979 Jul 20; 228(1-4):637-8. PubMed ID: 485529
    [No Abstract] [Full Text] [Related]

  • 10. [A case report of uterine hemorrhage following the insertion of the Medusa intrauterine contraceptive device in the presence of uterine adenomyosis].
    Cherveniashki S, Vasilev D.
    Akush Ginekol (Sofiia); 1990 Jul 20; 29(4):81-2. PubMed ID: 2267989
    [No Abstract] [Full Text] [Related]

  • 11. Intra-uterine contraception.
    Hawkins DF.
    Practitioner; 1970 Jul 20; 205(225):20-9. PubMed ID: 5479575
    [No Abstract] [Full Text] [Related]

  • 12. [A case of intolerance to a contraceptive intrauterine device].
    Konieczny A.
    Wiad Lek; 1983 Dec 01; 36(23):1995-8. PubMed ID: 6675310
    [No Abstract] [Full Text] [Related]

  • 13. Preliminary report of a trial of a long acting antihistaminic, buclizine hydrochloride in patients with bleeding after insertion of an intrauterine device.
    Bedi P, Devi PK, Chaudhury RR.
    Indian J Med Res; 1968 Jun 01; 56(6):884. PubMed ID: 4386522
    [No Abstract] [Full Text] [Related]

  • 14. [Results of personal observations on intrauterine contraception].
    Jaworski E.
    Wiad Lek; 1974 Feb 15; 27(4):333-6. PubMed ID: 4814001
    [No Abstract] [Full Text] [Related]

  • 15. [Prostaglandin E2 receptor and uterine bleeding caused by intrauterine devices].
    Zhu YP.
    Zhonghua Fu Chan Ke Za Zhi; 1987 Jul 15; 22(4):226-8, 254. PubMed ID: 2889584
    [No Abstract] [Full Text] [Related]

  • 16. Recommended procedures for the statistical evaluation of intrauterine contraception.
    Tietze C, Lewit S.
    Stud Fam Plann; 1973 Feb 15; 4(2):35-42. PubMed ID: 4691024
    [No Abstract] [Full Text] [Related]

  • 17. [Case of intrauterine rupture of Lippes loop].
    Blaziak M, Liber B.
    Wiad Lek; 1973 May 01; 26(9):847-8. PubMed ID: 4706379
    [No Abstract] [Full Text] [Related]

  • 18. [Current knowledge of intrauterine contraception (author's transl)].
    Andolsek L.
    Lijec Vjesn; 1976 Sep 01; 98(9):469-74. PubMed ID: 1011921
    [No Abstract] [Full Text] [Related]

  • 19. Performance of the Dalkon Shield intrauterine device.
    Jones RW.
    N Z Med J; 1975 Aug 13; 82(545):85-7. PubMed ID: 1058347
    [Abstract] [Full Text] [Related]

  • 20. Intrauterine contraception with the Antigon-F device.
    Cederqvist LL, Lauersen NH, Donovan S, Fuchs F.
    Adv Plan Parent; 1975 Aug 13; 10(1):23-8. PubMed ID: 1164984
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.